Levy D, Thirlway F, Sweanor D, Liber A, Sanchez-Romero L, Meza R
Nicotine Tob Res. 2023; 25(12):1810-1821.
PMID: 36692328
PMC: 10664083.
DOI: 10.1093/ntr/ntad014.
Kim S, Friedman T
Tob Use Insights. 2022; 15:1179173X221076419.
PMID: 35237081
PMC: 8883376.
DOI: 10.1177/1179173X221076419.
Levy D, Liber A, Cadham C, Sanchez-Romero L, Hyland A, Cummings M
Tob Control. 2022; 32(5):575-582.
PMID: 35074930
PMC: 9346571.
DOI: 10.1136/tobaccocontrol-2021-056971.
Lu J, Lee E
J Med Internet Res. 2021; 23(12):e28042.
PMID: 34964716
PMC: 8756341.
DOI: 10.2196/28042.
Haupt M, Xu Q, Yang J, Cai M, Mackey T
J Med Internet Res. 2021; 23(10):e28069.
PMID: 34714245
PMC: 8590191.
DOI: 10.2196/28069.
Re-exploring the early relationship between teenage cigarette and e-cigarette use using price and tax changes.
Pesko M, Warman C
Health Econ. 2021; 31(1):137-153.
PMID: 34672061
PMC: 9467387.
DOI: 10.1002/hec.4439.
Public health implications of vaping in the USA: the smoking and vaping simulation model.
Levy D, Tam J, Sanchez-Romero L, Li Y, Yuan Z, Jeon J
Popul Health Metr. 2021; 19(1):19.
PMID: 33865410
PMC: 8052705.
DOI: 10.1186/s12963-021-00250-7.
An Analysis of the FTC's Attempt to Stop the Altria-Juul Labs Deal.
Levy D, Douglas C, Sanchez-Romero L, Cummings K, Sweanor D
Tob Regul Sci. 2020; 6(4):302-305.
PMID: 32901222
PMC: 7475750.
DOI: 10.18001/TRS.6.4.7.
Cigarette smokers' concurrent use of smokeless tobacco: dual use patterns and nicotine exposure.
Felicione N, Ozga-Hess J, Ferguson S, Dino G, Kuhn S, Haliwa I
Tob Control. 2020; 30(1):24-29.
PMID: 32051253
PMC: 7423753.
DOI: 10.1136/tobaccocontrol-2019-055345.
Acute effects of JUUL and IQOS in cigarette smokers.
Maloney S, Eversole A, Crabtree M, Soule E, Eissenberg T, Breland A
Tob Control. 2020; .
PMID: 32041833
PMC: 7864587.
DOI: 10.1136/tobaccocontrol-2019-055475.
Investigating gateway effects using the PATH study.
Lee P, Fry J
F1000Res. 2020; 8:264.
PMID: 31956397
PMC: 6950312.
DOI: 10.12688/f1000research.18354.2.